Related references
Note: Only part of the references are listed.Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics
Gauri G. Rao et al.
THERAPEUTIC DRUG MONITORING (2020)
Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics?
Sara Baldelli et al.
THERAPEUTIC DRUG MONITORING (2020)
Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis
Wael A. Alghamdi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Different Underlying Mechanism Might Explain the Absence of a Significant Difference in Area Under the Concentration-Time Curve of Linezolid for Different ABCB1 Genotypes
Mathieu S. Bolhuis et al.
THERAPEUTIC DRUG MONITORING (2019)
A Common mdr1 Gene Polymorphism is Associated With Changes in Linezolid Clearance
Sarah Allegra et al.
THERAPEUTIC DRUG MONITORING (2018)
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients
Piergiorgio Cojutti et al.
CLINICAL PHARMACOKINETICS (2018)
Is it time to revise linezolid dose in elderly patients?
Marco Tinelli et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy
Liang Gong et al.
PHARMACOGENETICS AND GENOMICS (2017)
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
Federico Pea et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients
Yasuhiro Tsuji et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones
Dario Cattaneo et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Therapeutic drug management of linezolid: a missed opportunity for clinicians?
Dario Cattaneo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models
Nuggehally R. Srinivas et al.
DRUGS IN R&D (2016)
Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis
Akosua Adom Agyeman et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2016)
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
Ingrid Lunde et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients
Kazuaki Matsumoto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
P450 Oxidoreductase*28 ( POR*28) and Tacrolimus Disposition in Pediatric Kidney Transplant Recipients-A Pilot Study
Violette M. G. J. Gijsen et al.
THERAPEUTIC DRUG MONITORING (2014)
Pharmacokinetics of Intravenous Linezolid in Moderately to Morbidly Obese Adults
Amira A. Bhalodi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Risk Factors for a Low Linezolid Trough Plasma Concentration in Acute Infections
Laura Morata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections
Dario Cattaneo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Population Pharmacokinetic Analysis of Linezolid in Low Body Weight Patients With Renal Dysfunction
Yasuhiro Tsuji et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy
Laure Elens et al.
PHARMACOGENOMICS (2013)
Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem
Kathrin Klein et al.
Frontiers in Genetics (2013)
Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism
Kuan Gandelman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction
Yasuhiro Tsuji et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2011)
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)
Laura M. Hodges et al.
PHARMACOGENETICS AND GENOMICS (2011)
The P450 oxidoreductase*28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients
Hylke de Jonge et al.
PHARMACOGENOMICS (2011)
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetics of linezolid in septic patients with and without extended dialysis
Stefanie Swoboda et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction
Kazuaki Matsumoto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Determination of Linezolid in Human Plasma by High-Performance Liquid Chromatography With Ultraviolet Detection
Dario Cattaneo et al.
THERAPEUTIC DRUG MONITORING (2010)
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
King Leung Fung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations
Ningwu Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Linezolid for the treatment of multidrug-resistant tuberculosis
J Fortún et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Linezolid and rifampin:: Drug interaction contrary to expectations?
H Egle et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
DL Kroetz et al.
PHARMACOGENETICS (2003)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
Linezolid - A review of its use in the management of serious Gram-positive infections
CM Perry et al.
DRUGS (2001)
Share Paper
